Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Glyceryl trinitrate 2 mg buccal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Some |
|
Product containing precisely glyceryl trinitrate 3 milligram/1 each conventional release buccal tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Some |
|
Glyceryl trinitrate 5 mg buccal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Some |
|
Product containing precisely glyceryl trinitrate 300 microgram/1 each conventional release sublingual tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 300 microgram/1 each conventional release sublingual tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 500 microgram/1 each conventional release sublingual tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 500 microgram/1 each conventional release sublingual tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 600 microgram/1 each conventional release sublingual tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 600 microgram/1 each conventional release sublingual tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 6.5 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 9 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 2.5 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 2 milligram/1 gram conventional release rectal ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 2 milligram/1 gram conventional release rectal ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 208.333 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 208.333 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 416.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 416.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 625 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 625 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 400 microgram/actuation sublingual spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 400 microgram/actuation sublingual spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 10 milligram/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 10 milligram/10 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 50 milligram/50 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 50 milligram/50 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 5 milligram/5 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 5 milligram/5 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 50 milligram/10 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 50 milligram/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 25 milligram/5 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 25 milligram/5 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing only glyceryl trinitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing only glyceryl trinitrate in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing only glyceryl trinitrate in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing only glyceryl trinitrate in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate only product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 1 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 1 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 2 mg buccal tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 2 mg buccal tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 3 milligram/1 each conventional release buccal tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 3 milligram/1 each conventional release buccal tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 5 mg buccal tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 5 mg buccal tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 400 microgram sublingual tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 400 microgram sublingual tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 1 milligram/1 each prolonged-release buccal tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 1 milligram/1 each prolonged-release buccal tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 3 milligram/1 each prolonged-release buccal tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 3 milligram/1 each prolonged-release buccal tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 5 milligram/1 each prolonged-release buccal tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 5 milligram/1 each prolonged-release buccal tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 2 mg prolonged-release buccal tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 2 mg prolonged-release buccal tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 400 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 400 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 600 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 600 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 800 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Glyceryl trinitrate 800 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 200 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 200 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |
Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glyceryl trinitrate |
Inferred relationship |
Some |
1 |